[Skip navigation] FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule
CDER Home About CDER Drug Information Regulatory Guidance CDER Calendar Specific Audiences CDER Archives
 
Powered by Google
 

Rulemaking History for OTC Dandruff, Seborrheic, Dermatitis and Psoriasis Drug Products
View by Date

Final Monograph (21 CFR part 358 subpart H):
Miscellaneous External Drug Products for Over-the-Counter Human Use: Dandruff, Seborrheic Dermatitis, and Psoriasis Drug Products

OTC Dandruff, Seborrheic, Dermatitis and Psoriasis Drug Products found on this page:

Note: This page links to PDF files which require the free Adobe Acrobat Reader.


Dandruff, Seborrheic, Dermatitis, and Psoriasis Drug Products: Original Active Ingredients and Labeling
Advance Notice Of Proposed Rulemaking Date FR Citation
Notice: Advisory review panel change 3/6/1979 44FR12271
Advance Notice Of Proposed Rulemaking 12/3/1982 47FR54646
    Correction 2/8/1983 48FR5761
Extension of Comment Period 2/8/1983 48FR5762
    Correction 2/28/1983 48FR8261
Proposed Rule Date FR Citation
Tentative Final Monograph 7/30/1986 51FR27346
    Correction 11/25/1986 51FR42676
Extension of Comment Period 10/1/1986 51FR35003
Proposed Rule: Classifies category II and III ingredients without data as nonmonograph 5/16/1990 55FR20434
    Correction 6/7/1990 55FR23235
Final Rule Date FR Citation
Final Rule: Classifies category II and III ingredients without data as nonmonograph 11/7/1990 55FR46914
    Correction 12/3/1990 55FR49973
    Technical Amendment: Correct an ingredient name 1/30/1992 57FR3526
Final Monograph 12/4/1991 56FR63554
    Correction 1/17/1992 57FR2136

Dandruff, Seborrheic, Dermatitis, and Psoriasis Drug Products: Time and Extent Applications
Advance Notice Of Proposed Rulemaking Date FR Citation
Request for Data: Piroctone olamine 2/18/2004 69FR7652
    Extension of Comment Period 5/19/2004 69FR28932
Request for Data: Climbazole 12/5/2005 70FR72448

Dandruff, Seborrheic, Dermatitis, and Psoriasis Drug Products: Coal Tar and Menthol
Proposed Rule Date FR Citation
Proposed Rule: Adds combination 12/9/2005 70FR73178
Final Rule Date FR Citation
Final Rule 3/6/2007  72FR9849

Dandruff, Seborrheic, Dermatitis, and Psoriasis Drug Products: Selenium Sulfide
Proposed Rule Date FR Citation
Proposed Rule: Adds 0.6% micronized selenium sulfide 4/5/1993 58FR17554
Final Rule Date FR Citation
Final Rule 1/28/1994 59FR4000

Dandruff, Seborrheic, Dermatitis, and Psoriasis Drug Products: Nonmonograph Ingredients
Proposed Rule Date FR Citation
Proposed Rule: Classifies category II and III ingredients without data as nonmonograph 5/16/1990 55FR20434
    Correction 6/7/1990 55FR23235
Final Rule Date FR Citation
Final Rule: Classifies category II and III ingredients without data as nonmonograph 11/7/1990 55FR46914
    Correction 12/3/1990 55FR49973
    Technical Amendment: Corrects an ingredient name 1/30/1992 57FR3526

top arrow Back to Top     back arrow Back to Rulemaking Index

Date created: December 28, 2006; Last updated: May 4, 2007

horizonal rule